02396.HK
B&K Corporation Limited
HKSE · Healthcare · Biotechnology · CN
HKD 4.70
+4.44%Aug 16, 2026, 10:17 UTC
Qingcheng New Drug reported an interim loss of RMB 122 million for the six months ended June 2026, widening from RMB 86.68 million a year earlier, with no dividend declared.
Source:Jul 17, 2026, 08:49 UTC
Hua Ran Bio (02396.HK) announced that its stock short name will change to 'Qingcheng New Drug-B' from July 22, 2026.